Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9863 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 50 51 52 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Inotrem S.A.. (3/13/14). "Press Release: Inotrem Raises EUR18 Million to Develop Innovative Sepsis Treatments in a Series A Financing Co-led by Edmond de Rothschild Investment Patners and Sofinnova Partners". Paris & Nancy. 2014-03-13
Bayer AG. (3/13/14). "Press Release: Pulmonary Arterial Hypertension (PAH). Start of Phase IIIb Study with Bayer’s Riociguat in PAH Patients who Demonstrate an Insufficient Response to PDE-5 Inhibitors [Not intended for U.S. and UK Media]". Berlin. 2014-03-13
Actelion Ltd.. (3/13/14). "Press Release: Actelion Provides Update on Asahi Litigation". Allschwil. 2014-03-13
Sysmex Corporation. (3/13/14). "Press Release: Sysmex Enters into Clinical Research, Joint Development and Licensing Agreement with Merck Millipore". 2014-03-13
Vectura Group plc. (3/13/14). "Press Release: Acquisition of Activaero". Chippenham. 2014-03-13
DISCO project. (3/13/14). "Press Release: Planning for the Future. Successful DISCO Kick-Off at Cumberland Lodge, UK". 2014-03-13
Bicoll GmbH. (3/12/14). "Press Release: 40,000 Historic Formulations as Starting Point for New Drugs. Research Project EPICLEAP Receives Partial Funding from the German Federal Ministry of Education and Research". Munich & Berlin. 2014-03-12
Formycon AG. (3/12/14). "Press Release: Licensing Out of the First Biosimilar Development Project Already Enables Extension of the Product Pipeline as of 2014". Munich. 2014-03-12
Paion AG. (3/12/14). "Press Release: Paion AG Reports Financial Results for the Full Year 2013". Aachen. 2014-03-12
Ecron Acunova GmbH. (3/12/14). "Press Release: Anders Malm Appointed Managing Director at Ecron Acunova GmbH". Marlborough. 2014-03-12
Qiagen N.V.. (3/12/14). "Press Release: Qiagen N.V. Announces Successful Completion of Non-U.S. Offer Involving Convertible Notes". Hilden. 2014-03-12
Chemie.DE Information Service GmbH. (3/11/14). "Press Release: All the Important Trade Fairs, Congresses, Seminars and Webinars at a Glance". Berlin. 2014-03-11
Glycotope GmbH. (3/11/14). "Press Release: Glycotope Secures One of the Largest Financing Rounds in the European Biotech Sector". Berlin. 2014-03-11
Bayer AG. (3/11/14). "Press Release: Phase III Trial of Sorafenib as Adjuvant Therapy for Liver Cancer Did Not Meet Primary Endpoint [Not intended for U.S. and UK Media]". Berlin. 2014-03-11
Bayer AG. (3/11/14). "Press Release: Bayer to Invest More than 500 Million Euros for the Manufacturing of Hemophilia A Products Currently in Development [Not intended for U.S. and UK Media]". Leverkusen. 2014-03-11
Galenica. (3/11/14). "Press Release: Results of the Galenica Group for 2013". Bern. 2014-03-11
Exosome Diagnostics, Inc.. (3/11/14). "Press Release: Exosome Diagnostics Raises $27 Million in Series B Financing". New York City. 2014-03-11
Tecan Group Ltd.. (3/11/14). "Press Release: Full Year 2013. Tecan Records Higher Profit and Important Progress in the Implementation of Its Strategy". Männedorf. 2014-03-11
CureVac GmbH. (3/10/14). "Press Release: CureVac Wins Two Million EUR from Inaugural European Commission Vaccine Prize. RNActive Vaccines Offer Excellent Conditions for Cost-effective Worldwide Distribution". Tübingen & Brussels. 2014-03-10
Kythera Biopharmaceuticals, Inc.. (3/10/14). "Press Release: Kythera Acquires Rights to ATX-101 Outside of the US and Canada from Bayer Consumer Care". Calabasas, CA. 2014-03-10
Sony DADC. (3/10/14). "Press Release: Sony DADC and Opko Diagnostics Announce Manufacturing Partnership". Salzburg & Miami, FL. 2014-03-10
Eppendorf AG. (3/10/14). "Press Release: Eppendorf’s New Mastercycler Nexus X2 Provides Multi-block Solution for High Volume, Simultaneous PCR Runs". Hamburg. 2014-03-10
Symrise AG. (3/10/14). "Press Release: Symrise Achieves Record Levels in Sales and Profitability in 2013". 2014-03-10
EMD Millipore. (3/10/14). "Press Release: EMD Millipore Receives Grant from Massachusetts Life Sciences Center to Collaborate with Promethera Biosciences". Billerica, MA. 2014-03-10
Biognosys AG. (3/7/14). "Press Release: Biognosys and FGCZ Announce Collaboration on SpectroDive PRM Testing". Zürich-Schlieren. 2014-03-07
Merck KGaA. (3/6/14). "Press Release: Merck Reports Record Result for 2013". Darmstadt. 2014-03-06
Boehringer Ingelheim. (3/6/14). "Press Release: Boehringer Ingelheim Announces Phase 3 SVR12 Results in HCV/HIV Co-infected Patients Treated Faldaprevir [For media outside of the US, the UK & Canada only]". Ingelheim & Ridgefield, CT. 2014-03-06
Boehringer Ingelheim. (3/6/14). "Press Release: Pradaxa (dabigatran etexilate) Now Approved in more than 100 Countries for Stroke Prevention in Atrial Fibrillation [For media outside of the US, the UK & Canada only]". Ingelheim & Ridgefield, CT. 2014-03-06
Debiopharm S.A.. (3/6/14). "Press Release: Debiopharm Group to Acquire Products or Companies to Expand Activities at Manufacturing Facility in Martigny (Valais, Switzerland)". Lausanne. 2014-03-06
Merck KGaA. (3/6/14). "Press Release: Merck’s Consumer Health Division Breaks $1bn Barrier through Transition of Neurobion and Floratil Brands from Merck Serono". Darmstadt. 2014-03-06
Debiopharm S.A.. (3/5/14). "Press Release: Immunexpress Closes USD 6 Million Financing Round Led by Debiopharm Group". Lausanne & Seattle, WA. 2014-03-05
Evolva Holding S.A.. (3/5/14). "Press Release: Exercise of Over-allotment Option in Evolva’s Share Placement [Not for Distribution in or into the United States, Canada, Australia or Japan]". Reinach. 2014-03-05
MeVis Medical Solutions AG. (3/5/14). "Press Release: Preliminary Figures 2013". Bremen. 2014-03-05
Agenus Inc.. (3/5/14). "Press Release: Agenus Reports Fourth Quarter and Full Year 2013 Financial Results". Lexington, MA. 2014-03-05
KCR S.A.. (3/4/14). "Press Release: KCR Strenghtens Its Footprint in Western Europe. Dynamic European CRO Registers New Entities in the UK and Germany". Warsaw. 2014-03-04
Curetis AG. (3/4/14). "Press Release: Curetis Prepares Launch of Second Unyvero Application". Holzgerlingen. 2014-03-04
EKF Diagnostics Holdings plc. (3/4/14). "Press Release: Transfer of Production". 2014-03-04
Evolva Holding S.A.. (3/4/14). "Press Release: Evolva Reaches Second Milestone Roquette Collaboration". Reinach. 2014-03-04
ProBioGen AG. (3/4/14). "Press Release: ProBioGen and Merus Sign Deal on GlymaxX ADCC Enhancement Technology". Berlin & Utrecht. 2014-03-04
Roche. (3/4/14). "Press Release: Roche Annual General Meeting 2014. Christoph Franz Elected as Chairman of the Board of Directors – 27th Consecutive Dividend Increase". Basel. 2014-03-04
4SC AG. (3/4/14). "Press Release: 4SC AG Issues First Tranche of Convertible Notes with a Nominal amount of EUR 500,000 to Yorkville". Planegg-Martinsried. 2014-03-04
Thermo Fisher Scientific Inc.. (3/3/14). "Press Release: Thermo Fisher Scientific Strenghtens Innovation Leadership with New Products Launched at Pittcon 2014". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: Bruker Launches Next-generation GC-APCI II GC-MS Interface with Automatic MS Calibration for Metabolomics and Small Molecule Research". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: Bruker Launches New autoflex speed MALDI-TOF(/TOF) with 2 kHz Smartbeam Laser". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: Bruker Announces Next Generation JuiceScreener 3.0". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: MIR-FIR Spectroscopy in One Step – an FT-IR Dream Becomes a Reality". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: At Pittcon 2014, Bruker Introduces Numerous New and Enhanced Customer-driven Products for Life-Science Research, Industrial and Applied Markets". Chicago, IL. 2014-03-03
Bruker Corporation. (3/3/14). "Press Release: Bruker’s New TopSolids Software Provides Accelerated Workflow in Solid-state NMR for the Characterization of Protein Structures". Chicago, IL. 2014-03-03
MorphoSys AG. (3/3/14). "Press Release: MorphoSys to Start Share Buy-back Program". 2014-03-03
Roche. (3/3/14). "Press Release: Roche Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer". Basel. 2014-03-03
Sartorius AG. (3/3/14). "Press Release: Sartorius Reviews Fiscal 2013 Results". Göttingen. 2014-03-03
Boehringer Ingelheim. (3/1/14). "Press Release: AAAAI 2014. Asthma – New Phase III Data Show Tiotropium Respimat Effective Across Asthma Severities [For Media outside the U.S., Canada and UK]". San Diego, CA. 2014-03-01
Poly-Pico Technologies Ltd.. (3/14). "Press Release: New Open Access Platform Desktop Spotter to Be Unveiled at Analytica in Germany". 2014-03-01
Biognosys AG. (2/28/14). "Press Release: Biognosys Introduces New Multiplexed MRM Assay Panel for Depleted Plasma – PlasmaDeepDive". Zürich-Schlieren. 2014-02-28
Roche. (2/28/14). "Press Release: Roche and Discuva Join Forces to Combat Life-threatening Infections Caused by Multi-drug Resistant Bacteria". Basel & Cambridge. 2014-02-28
MorphoSys AG. (2/28/14). "Press Release: MorphoSys AG Reports Results for Fiscal Year 2013. Financial Results at the Upper End of 2013 Guidance". 2014-02-28
Spark Holland B.V.. (2/28/14). "Press Release: Spark Holland Innovative Technology Used in Gerstel Integrated Solutions. Spark Holland OEM Agreement Including Patented DBS Technology". 2014-02-28
microDimensions GmbH. (2/27/14). "Press Release: microDimensions GmbH Successfully Closes Seed Round". Munich. 2014-02-27
InSphero AG. (2/27/14). "Press Release: InSphero Granted Hanging Drop Patents in China and Japan". Schlieren. 2014-02-27
Adocia S.A.. (2/27/14). "Press Release: Adocia Announces Preliminary Positive Clinical Results for Its Combination of Long-acting Insulin Glargine and Fast-acting Insulin Analog Lispro, BioChaperone Combo". Lyon. 2014-02-27
Epigenomics AG. (2/26/14). "Press Release: Epigenomics AG Reports Preliminary Results and Highlights for the Year Ended December 31, 2013". Berlin & Germantown, MD. 2014-02-26
Algeta ASA. (2/26/14). "Press Release: Bayer’s Voluntary Cash Offer to Acquire the Entire Issued Share Capital of Algeta Is Successful". Oslo. 2014-02-26
Evolva Holding S.A.. (2/26/14). "Press Release: Evolva Successfully Places New Shares". 2014-02-26
BRAIN AG. (2/25/14). "Press Release: BRAIN Takes Over Anti-bitter Patents and Utility Patent Portfolio from BASF". Zwingenberg. 2014-02-25
Wilex AG. (2/24/14). "Press Release: Professor Olaf G. Wilhelm Leaves the Executive Management Board on 31 March 2014, Dr Jan Schmidt-Brand Will Lead the Company". Munich. 2014-02-24
Roche. (2/21/14). "Press Release: Roche Signs Licensing Agreement with Sysmex Inostics GmbH for emPCR Patent Portfolio". Pleasanton, CA. 2014-02-21
Roche. (2/21/14). "Press Release: Roche Launches New Test to Provide the Most Comprehensive Portfolio for Cervical Cancer Screening. New Automated CINtec Plus Test Improves the Detection of Cervical Pre-cancer". Basel. 2014-02-21
Givaudan S.A.. (2/21/14). "Press Release: Givaudan Strengthens Process Development and Research Capabilities. Enters into Exclusive Negotations with ARD to Acquire Soliance". Geneva. 2014-02-21
BB Biotech AG. (2/20/14). "Press Release: Publication of 2013 Annual Report of BB Biotech AG". 2014-02-20
High-Tech Gründerfonds Management GmbH. (2/20/14). "Press Release: Amal Therapeutics SA Raises Seed Round from Boehringer Ingelheim Venture Fund and High-Tech Gründerfonds to Develop Therapeutic Cancer Vaccines Based on Its Proprietary Technology Platfor 2014-02-20
Merck KGaA. (2/20/14). "Press Release: Merck Appoints Simon Sturge as New Head of Biosimilars Unit". Darmstadt. 2014-02-20
Proteros Biostructures GmbH. (2/20/14). "Press Release: Proteros Announces Election of Prof. Eric-Paul Pâques, CEO of Grünenthal, as New Supervisory Board Member". Munich. 2014-02-20
LifeLabs Medical Laboratory Services. (2/19/14). "Press Release: LifeLabs Medical Laboratory Services Acquires Centogene’s Canadian Business". Toronto, ON. 2014-02-19
Bruker Corporation. (2/18/14). "Press Release: Bruker Reports Fourth Quarter and Full Year 2013 Financial Results". Billerica, MA. 2014-02-18
Ionicon Analytik GmbH. (2/18/14). "Press Release: Ionicon Launches the New Super-fast PTR-TOF 1000 Trace Gas Analyzer". Innsbruck. 2014-02-18
Novimmune S.A.. (2/18/14). "Press Release: Novimmune Announces Closing of CHF 60 Million Financing". Geneva. 2014-02-18
BioOutsource Ltd.. (2/18/14). "Press Release: BioOutsource Expands ADC Characterisation Capabilities. A Global Leader in ADC Characterisation, BioOutsource, Partners with Glythera". Glasgow. 2014-02-18
Markes International Ltd.. (2/18/14). "Press Release: New Ground-breaking Ion Source Technology for GC-MS Launched at Pittcon 2014". 2014-02-18
Max-Delbrück-Centrum für Molekulare Medizin (MDC). (2/17/14). "Pressemitteilung: W3-Professuren für MDC- und Charité-Forscher". 2014-02-17
Stratec Biomedical AG. (2/17/14). "Press Release: Dr. Claus Vielsack Appointed Member of the Management Board of Stratec for Product Development". Birkenfeld. 2014-02-17
HBM Healthcare Investments Ltd.. (2/17/14). "Press Release: HBM Healthcare Investments Participates with EUR 20 Million in Financing Round of Advanced Accelerator Applications [Not for distribution in the USA, Canada, Japan or Australia]". Zug. 2014-02-17
Advanced Accelerator Applications S.A.. (2/17/14). "Press Release: Advanced Accelerator Applications Completes €41 Million Fund Raising". Saint-Genis-Pouilly. 2014-02-17
Horizon Discovery Ltd.. (2/17/14). "Press Release: Horizon Discovery Signs Supply and Distribution Agreement with Sirion Biotech GmbH". Cambridge. 2014-02-17
Boehringer Ingelheim. (2/17/14). "Press Release: Boehringer Ingelheim Receives East Bay Innovation Award". Fremont, CA. 2014-02-17
Boehringer Ingelheim GmbH. (2/17/14). "Pressemitteilung: IQWiG bescheinigt Zusatznutzen für Giotrif (afatinib)". Ingelheim. 2014-02-17
MorphoSys AG. (2/17/14). "Press Release: MorphoSys Announces Clinical Milestone in Anti-inflammatory Program". 2014-02-17
Novartis AG. (2/17/14). "Press Release: Novartis Expands Cancer Immunotherapy Research Program with Acquisition of CoStim". Basel. 2014-02-17
Universitätsmedizin Mainz. (2/14/14). "Pressemitteilung: Grundsteinlegung für Paul-Klein-Zentrum für Immunintervention. Universitätsmedizin Mainz bekommt einen hochmodernen Forschungsneubau". 2014-02-14
Enzymatics, Inc.. (2/14/14). "Press Release: Enzymatics Launches Archer NGS. Identifies Known and Novel Gene Fusions without Prior Knowledge of Breakpoints or Fusion Partners". Marco Island, FL. 2014-02-14
Analytik Jena AG. (2/13/14). "Press Release: Analytik Jena AG with Double-digit Sales and Earnings Growth after Three Months". Jena. 2014-02-13
Carl Zeiss Meditec AG. (2/13/14). "Press Release: Carl Zeiss Meditec AG – Cautious Start to the New Financial Year, after Strong Annual Results. Negative Currency Effects Hinder Growth in the First Quarter". Jena. 2014-02-13
Nestlé S.A.. (2/13/14). "Press Release: Full-year 2013 – 4.6% Organic Growth, Trading Operating Profit Magin up 20 Basis Points, up 40 Basis Points in Constant Currencies". Vevey. 2014-02-13
Mannheim. (2/13/14). "Pressemitteilung: Operation Zukunft – Sympbolischer Spatenstich für Medizintechnologie-Zentrum". 2014-02-13
Cytos Biotechnology AG. (2/13/14). "Press Release: Cytos Biotechnology Announces Full Year 2013 Financial Results". Schlieren. 2014-02-13
Agenus Inc.. (2/13/14). "Press Release: Agenus Closes Acquisition of 4-Antibody". Lexington, MA. 2014-02-13
Redx Pharma Ltd.. (2/12/14). "Press Release: €85 Million European Programme Targets Novel Antibiotics. Redx Pharma Joins Global Consortium to Tackle Growing Threat from Antibiotic Resistance". 2014-02-12
4SC AG. (2/12/14). "Press Release: Continued Funding of 4SC AG. Investor Undertakes to Subscribe to Convertible Notes for up to EUR 15 Million Nominally [Ad hoc Announcement] ". Planegg-Martinsried. 2014-02-12
Ganymed Pharmaceuticals AG. (2/12/14). "Press Release: Ganymed’s IMAB027 Enters Phase I/II Clinical Trial for Ovarian Cancer". Mainz. 2014-02-12
High-Tech Gründerfonds Management GmbH. (2/12/14). "Press Release: Coramaze Technologies GmbH Receives € 1 Million to Develop an Innovative Medical Device for the Minimally Invasive Treatment of Heart Valve Diseases". Essen, Dortmund & Bonn. 2014-02-12
Paion AG. (2/12/14). "Press Release: Paion Completes Private Placement through the Issuance of New Shares in a Placement Volume of EUR 3.17 Million [Not for distribution or release, directly or indirectly, in or into the United States or any other jurisd 2014-02-12
next pagenext page 1 2 3 ... 50 51 52 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top